Real talk about AI and advancing cancer treatments

Christopher Lieu, MD, trained at a top cancer hospital, yet many of the treatments that were standard of care at that time are no longer used. When he finished his fellowship in 2011, most patients with cancer were treated with a “one-size-fits-all strategy, with what he calls “chemical-warfare-type treatment.” But now, a rapid evolution of targeted, personalized medicine to treat certain types of cancer has occurred, said Lieu, professor of medicine and medical oncology at the University of Colorado School of Medicine, and artificial intelligence (AI) is pushing the envelope.